Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Neurocrine Biosciences

Neurocrine Biosciences reported $374.1M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 224.3M 98.67M
Acorda Therapeutics ACOR:US USD 34.74M 3.21M
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
Amgen AMGN:US USD 14.22B 1.47B
Biogen BIIB:US USD 3.01B 257.9M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Cytokinetics CYTK:US USD 75.22M 9.4M
Dynavax Technologies DVAX:US USD 91.52M 58.56M
Enanta Pharmaceuticals ENTA:US USD 32.17M 9.16M
Exelixis EXEL:US USD 327.6M 3.24M
Gilead Sciences GILD:US USD 10.53B 709M
Halozyme Therapeutics HALO:US USD 91.92M 38.87M
Incyte Corp INCY:US USD 1.01B 150.97M
Intercept Pharmaceuticals ICPT:US USD 207.12M 22.96M
Intra Cellular Therapies ITCI:US USD 79.59M 3.65M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
Prothena PRTA:US USD 48.88M 1.26M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Repligen RGEN:US USD 405.32M 1.12M
Rigel Pharmaceuticals RIGL:US USD 45.52M 19.69M
Sarepta Therapeutics SRPT:US USD 536.88M 82.72M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 10.41B 1.06B
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M
Vertex Pharmaceuticals VRTX:US USD 3.03B 284.1M